Monoclonal Mouse anti‑Human TRIM54 / MURF Antibody (clone OTI5D9, Carrier‑free, aa166‑400, WB) LS‑C790018
Monoclonal Mouse anti‑Human TRIM54 / MURF Antibody (clone OTI5D9, Carrier‑free, aa166‑400, WB) LS‑C790018
Antibody:
TRIM54 / MURF Mouse anti-Human Monoclonal (aa166-400) (Carrier-free) (OTI5D9) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
TRIM54 / MURF Mouse anti-Human Monoclonal (aa166-400) (Carrier-free) (OTI5D9) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
MURF antibody LS-C790018 is an unconjugated mouse monoclonal antibody to human MURF (TRIM54) (aa166-400). Validated for WB.
Target
Human TRIM54 / MURF
Synonyms
TRIM54 | MURF | MURF-3 | MuRF3 | RING finger protein 30 | Tripartite motif-containing 54 | RNF30 | Tripartite motif containing 54
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 166-400 of human TRIM54 (NP_115935) produced in E.coli.
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Source:
E. coli
Tag:
His, N-Terminal
Reactivity:
Human
Range:
78-5000 pg/ml
Reactivity:
Monkey
Range:
0.625-40 ng/ml
Species:
Applications:
ICC, Immunofluorescence, Flow Cytometry
Species:
Human
Applications:
Flow Cytometry
Species:
Pig
Applications:
Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024